Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 208-day study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evaluations (90 days).
Sponsor: COUR Pharmaceutical Development Company, Inc.
Check if you qualify for this type 1 diabetes clinical trial in Aurora, CO
If you're searching for type 1 diabetes treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.